5 factors that can make or break health care spending in 2022


In 2022, challenges will continue to mount for plan sponsors and their advisors as they battle to keep costs under control without gutting benefits. “The top cost drivers for 2022 are similar to those of 2021, with musculoskeletal conditions and cancer ranking number one and two, respectively, followed by diabetes, cardiovascular and high-risk maternity,” says Ellen Kelsay, president and CEO of Business Group on Health.

Prescription drug costs continue to accelerate at an alarming rate, specifically costs associated with specialty medications.”

Next Post

Biocon Biologics to acquire biosimilar assets from Viatris raising up to USD 3.335 billion in equity and cash

Biocon Biologics Ltd. , a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ) : VTRS ). Under the agreement, Biocon Biologics Ltd. (BBL) will acquire Viatris’ biosimilars business to create a fully integrated global biosimilars business. It […]